Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Studying movement patterns to help tell Parkinson's disease apart from other conditions early

Tests movement measurements in people with Parkinson's disease and healthy older adults.

Plain-language title generated from the registry record
Registry title: Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

Key facts

Where
Montreal, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 75 years old?

Source: NCT06161636, who can take part

Where in Canada

  • CHUM Université de MontréalMontreal, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre hospitalier de l'Université de Montréal (CHUM)
Trial code
NCT06161636
Record updated
14 February 2025
Original description
The working hypotheses are as follows: #1 The processing of performance signals by automated lognormal segmentation and the extraction of the parameters of interest will make it possible to distinguish groups of patients from healthy elderly subjects. #2 The three instrumental approaches will not have the same degree of reliability as a predictive biomarker of clinical diagnosis established by consensus.Read full original descriptionShow less

Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

The working hypotheses are as follows: #1 The processing of performance signals by automated lognormal segmentation and the extraction of the parameters of interest will make it possible to distinguish groups of patients from healthy elderly subjects. #2 The three instrumental approaches will not have the same degree of reliability as a predictive biomarker of clinical diagnosis established by consensus.

Inclusion: Being diagnosed with Parkinsonism including idiopathic Parkinson's disease or a related syndrome; Have motor symptoms of Parkinsonism for 6 years or less; Be a healthy volunteer subject in good general health with no prior neurological history; Age between 50-75 years old; If applicable, be able to safely leave home in the morning without having taken antiparkinsonian medication for the past 12 hours.

Exclusion: Major neurocognitive disorders; History of other neurological conditions, such as ischemic or hemorrhagic stroke, paralysis of a limb, traumatic brain injury, epilepsy, orofacial dystonia, essential tremor; History of oromandibular or laryngeal procedures; Uncorrected deafness; Any contraindication to pupillary dilation.

ClinicalTrials.gov NCT06161636